Company · Healthtech & Bio

Connectoma Neurotech

connectoma.com ↗ ·Madrid

Madrid-based neurotechnology startup (founded 2024) that combines AI, fMRI brain mapping and EEG with millimeter-precision neuronavigation to deliver personalized transcranial magnetic stimulation (TMS) for treatment-resistant depression, anxiety, OCD and substance use disorders. Reports remission rates up to 79% versus ~40% for standard TMS. Early-stage: backed by a Red.es public innovation grant and investment from Bolboreta Innova Group.

Founded
2024
Founders
3
News
1
Rounds
0
Investors
1
SectorsMental Health, Neurotechnology, Medical Devices, AI Start-up MapHealthtech & Bio › Consumer & telehealth services

Profile updated 3 Aug 2026

Founders

Alfonso Tames Llana
Co-Founder & CTO
Daniel Díez García
Co-Founder & CEO
Jaime Adán Manes
Co-Founder & Chief Scientific Officer (Psychiatrist)

Global models

No comparables on record yet.

Investors 1

Bolboreta Innova Group
www.bolboretainnova.com
Investor Spain

Funding rounds

No announced rounds on record.

News & media 1

PublishedArticle
2026-04-27 Connectoma llega a Madrid: hasta 79% de remisión para depresión resistente en 5 días ↗
Democrata.es
Start typing to search across everything.
↑↓ navigate↵ openesc close